ANLON HEALTHCARE LIMITED

Anlon Healthcare Limited held its Q1 FY27 earnings conference call on August 6, 2026, where management discussed the company's financial performance and strategic developments. Management reported a consolidated total income of 87.62 crore, a significant increase from 33.31 crore in Q1 FY26, driven by the consolidation of the recent acquisition of Remember India Health links and organic growth. The EBITDA margin moderated to approximately 17% due to rising raw material prices and the integration of the new acquisition, which is currently in a turnaround phase. Management set a goal for EBITDA margins to recover to the 25% to 30% range in the upcoming quarters. The acquisition of Remember India Health links marks a strategic shift towards finished dosage formulation, expanding Anlon's capabilities beyond APIs. Management expressed confidence in achieving a revenue CAGR of approximately 30% over the next three years, supported by their expanded manufacturing platform and product portfolio.

Management highlighted both growth opportunities and challenges related to margin pressures.